Table 2.
Groups/dose (mg/kg) | Inflam. severity (0-3) | Inflam. extent (0-3) | Leucocyte infiltration (0-3) | Crypt Damage (0-4) | Total colitis index (0-13) |
---|---|---|---|---|---|
Normal | 0.0 (0-0) | 0.0 (0-0) | 0.0 (0-0) | 0.0 (0-0) | 0.0 (0-0) |
Control colitis | 3.0 (3-3) ### | 3.0 (3-3) ### | 3.0 (2-3) ### | 4.0 (3-4) ### | 12.5 (12-13) ### |
SSAE 150 | 3.0 (2-3) | 3.0 (2-3) | 3.0 (2-3) | 3.5 (2-4) | 11.6 (9-13) |
SSAE 300 | 3.0 (2-3) | 3.0 (2-3) | 2.5 (1-3) | 3.0 (2-4) | 10.8 (7-13) |
SSAE 600 | 2.5 (1-3) | 2.5 (2-3) | 2.0 (1-3) | 3.0 (2-3) * | 9.0 (6-12)* |
SSHE 150 | 2.0 (1-2)*** | 2.0 (1-3)* | 2.0 (1-2)* | 2.5 (1-3)* | 8.6 (4-10)** |
SSHE 300 | 1.5 (0-2)*** | 2.0 (1-2)* | 1.0 (1-2)*** | 2.0 (1-3)** | 6.3 (3-7) *** |
SSHE 600 | 1.0 (0-2)*** | 1.0 (1-2)***,+ | 1.0 (1-1)*** | 1.5 (1-2)***,+ | 4.6 (3-7) ***+ |
Dex.1 | 1.0 (0-1)*** | 1.0 (0-1)*** | 1.0 (0-1)*** | 1.0 (1-1)*** | 3.1 (1-5) *** |
Mes.100 | 2.0 (1-3)* | 1.5 (1-3)** | 2.0 (1-2)* | 3 (2-3)* | 8.4 (5-11) ** |
Data are presented as Means±SEM (n=6). Dex. (Dexamethasone), Mes. (Mesalazine). The differences between groups were calculated based on Mann-Whitney test. *P<0.05, **P<0.01, ***P<0.001 represent significant difference compared to control group, +P<0.05 represent significant difference compared to SSAE 600 mg/kg, ###P<0.001 represent significant difference compared to normal group